CTOs on the Move

Diamond Herpanacine Assoc

www.diamondformulas.com

 
Diamond Herpanacine Assoc is a Glenside, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MyHealth Centre

MyHealth Centre is a unique collaborative partnership of medical professionals and health care industry experts established in order to deliver quality and innovation in patient care. MyHealth Centre is a leading manager of independently owned diagnostic imaging facilities in Ontario. We currently manage over 25 Independent Health Facilities (IHFs) with agreements to develop additional IHF licenses.

Parmer Eye Care

Parmer Eye Care is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Formulife

4x Award Winner WHETHER YOU HAVE AN EXISTING BRAND OR ARE LOOKING TO START UP A NEW LINE, FORMULIFE SUPPLEMENTS HAS THE EXPERIENCE AND FACILITY TO ASSIST YOUR BUSINESS EVERY STEP OF THE WAY.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.